AzTrials
AzTrials

Quadratus Lumborum BlockNCT05089994

Comparison of Two Approaches of Quadratus Lumborum Block for Post-operative Analgesia in Radical Cystectomy

A study testing US guided injection in people with Quadratus Lumborum Block, run by Assiut University at 1 site in Egypt.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

To compare the postoperative analgesic effect of two ultrasound guided approaches of quadratus lumborum block (QLB) (anterior and intramuscular) for radical cystectomy. Read more about this study

Who is it for?
Ages 40 to 70 years
Conditions the study is for
Quadratus Lumborum Block
What is being tested?
US guided injection
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
6 Oct 2021to 25 Sep 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 40 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age: 40-70years.
  • BMI: 20-30 kg.m2
  • Sex: both males and females.
  • American Society of Anesthesiologists (ASA )physical status: I-III.
  • Operation: radical cystectomy

Who cannot join

  • • Patient's refusal to participate in the study.
  • known allergy to local anesthesia (LA),
  • coagulopathy or thrombocytopenia,
  • body mass index (BMI) above 30 kg .m 2, and infection at site of injection.
  • Chronic pain syndromes,
  • Prolonged opioid medication,
  • Patients on regular use of analgesic or who received analgesic 24 h before surgery

Trial locations and contacts

1 site in 1 country.

Hassan Mostafa abdelbaky ahmed, Master contact

01060264751

hassan.mostafa9444@gmail.com

Abdel raheem Mahmoud Mohamed, Prof contact

01000032655

Egypt1 site, 1 recruiting
  • Assuit university urology hospital

    Asyut

    Hassan Mostafa abdelbaky, 01060264751, Hassan.mostafa9444@gmail.com

    Recruiting

Other trials in Egypt

About this study

Official title: Comparison of Two Approaches of Quadratus Lumborum Block for Post-operative Analgesia in Radical Cystectomy: Prospective-randomized Clinical Trial

To compare the postoperative analgesic effect of two ultrasound guided approaches of quadratus lumborum block (QLB) (anterior and intramuscular) for radical cystectomy.

Read the detailed description

The quadratus lumborum block (QLB) is one of the abdominal wall block techniques used to anesthetize thoracolumbar nerves . The QLB technique was described initially by Blanco et al. in 2007 (not published), then reported initially by Kadam in 2013. Since then, QLB has evolved with the development of the ultrasound-guided nerve block. To date, several randomized controlled trials have reported effective postoperative analgesia, with non-intramuscular QLB for cesarean sections, laparoscopic gynecologic surgery and hip hemiarthroplasty .

The intramuscular QLB (QLBi) technique was first reported by. This approach is different from others in tubouchi for QLB; although the injection target sites of the other approaches are planes around the quadratus lumborum muscle, the intramuscular approach penetrates the fascia of the quadratus lumborum muscle, where local anesthetics are injected. Therefore, QLBi is relatively easier to perform compared with other QLB approaches.

The incidence of urinary bladder cancer in the Middle East and Africa is greater in areas with high rather than low SH prevalence.

Being tested
US guided injection

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • US guided injectionProcedure or surgery

    using 2.5mg/kg of 0.25% bupivacaine diluted in a 20 mL syringe of normal saline , received ultrasound-guided quadratus lumborum.

Study groups in NCT05089994
Study groupRoleWhat they receive
Group 1 (QLBA) will include 30 patientsExperimentalwill receive ultrasound-guided anterior approach quadratus lumborum block
Receives: Procedure: US guided injection
Group 2 (QLBI)will include 30 patients.Experimentalreceived ultrasound-guided intramuscular quadratus lumborum.
Receives: Procedure: US guided injection

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate the first call for rescue analgesia

    The time of the first call of analgesia is recorded

    Measured: 24hours after recovery From anesthesia

Secondary outcomes (1)
  1. Total doses of morphine required

    Doses of morphine required postoperative

    Measured: 24hours after recovery from anesthesia

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Oct 2021
  2. Study start6 Oct 2021
  3. Primary completion4 Sep 2024 (estimated)
  4. Study completion25 Sep 2024 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Investigator, Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05089994
Sponsor's protocol ID
01060264751
Status last verified
Jun 2024
First submitted
22 May 2021
Last updated
31 Jul 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing US guided injection in people with Quadratus Lumborum Block, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 31 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hassan Mostafa abdelbaky ahmed, Master (01060264751, hassan.mostafa9444@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate the first call for rescue analgesia (time frame: 24hours after recovery From anesthesia). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jul 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in